» Articles » PMID: 29444743

Tumor-Suppressive MicroRNA-708 Targets Notch1 to Suppress Cell Proliferation and Invasion in Gastric Cancer

Overview
Journal Oncol Res
Specialty Oncology
Date 2018 Feb 16
PMID 29444743
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Growing evidence has demonstrated that numerous microRNAs (miRNAs) may participate in the regulation of gastric carcinogenesis and progression. This phenomenon suggests that gastric cancer-related miRNAs can be identified as effective therapeutic targets for this disease. miRNA-708 (miR-708) has recently been reported to be aberrantly expressed in several types of cancer and contribute to carcinogenesis and progression. However, the expression level, biological roles, and underlying mechanisms of miR-708 in gastric cancer are poorly understood. Here we found that miR-708 was downregulated in gastric cancer tissues and cell lines. Downregulated miR-708 expression was significantly associated with lymphatic metastasis, invasive depth, and TNM stage. Further investigation indicated that ectopic expression of miR-708 prohibited cell proliferation and invasion in gastric cancer. Bioinformatics analysis showed that Notch1 was a potential target of miR-708. Notch1 was further confirmed as a direct target gene of miR-708 in gastric cancer by dual-luciferase reporter assay, reverse transcription quantitative polymerase chain reaction, and Western blot analysis. Furthermore, an inverse association was found between miR-708 and Notch1 mRNA levels in gastric cancer tissues. In addition, restored Notch1 expression rescued the inhibitory effects on gastric cancer cell proliferation and invasion induced by miR-708 overexpression. Our findings highlight the tumor-suppressive roles of miR-708 in gastric cancer and suggest that miR-708 may be investigated as a novel target for gastric cancer treatment.

Citing Articles

Role and Involvement of TENM4 and miR-708 in Breast Cancer Development and Therapy.

Peppino G, Riccardo F, Arigoni M, Bolli E, Barutello G, Cavallo F Cells. 2022; 11(1).

PMID: 35011736 PMC: 8750459. DOI: 10.3390/cells11010172.


Melatonin inhibits proliferation and viability and promotes apoptosis in colorectal cancer cells via upregulation of the microRNA-34a/449a cluster.

Ji G, Zhou W, Li X, Du J, Li X, Hao H Mol Med Rep. 2021; 23(3).

PMID: 33398374 PMC: 7809902. DOI: 10.3892/mmr.2021.11826.


LINC00514 drives osteosarcoma progression through sponging microRNA-708 and consequently increases URGCP expression.

Yu D, Xu X, Li S, Zhang K Aging (Albany NY). 2020; 12(8):6793-6807.

PMID: 32325430 PMC: 7202513. DOI: 10.18632/aging.103043.


Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.

Yang Y, Qu A, Zhao R, Hua M, Zhang X, Dong Z Mol Oncol. 2018; 12(12):2072-2084.

PMID: 30242969 PMC: 6275280. DOI: 10.1002/1878-0261.12385.

References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Li Q, Li S, Wu Y, Gao F . miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3. Oncol Lett. 2017; 14(2):2552-2558. PMC: 5530066. DOI: 10.3892/ol.2017.6429. View

3.
Farazi T, Spitzer J, Morozov P, Tuschl T . miRNAs in human cancer. J Pathol. 2010; 223(2):102-15. PMC: 3069496. DOI: 10.1002/path.2806. View

4.
Guo P, Lan J, Ge J, Nie Q, Mao Q, Qiu Y . miR-708 acts as a tumor suppressor in human glioblastoma cells. Oncol Rep. 2013; 30(2):870-6. DOI: 10.3892/or.2013.2526. View

5.
Chu D, Zhou Y, Zhang Z, Li Y, Li J, Zheng J . Notch1 expression, which is related to p65 Status, is an independent predictor of prognosis in colorectal cancer. Clin Cancer Res. 2011; 17(17):5686-94. DOI: 10.1158/1078-0432.CCR-10-3196. View